JCRRF
Price
Loading...
Change
-$0.00 (-0.00%)
Updated
Loading...
Capitalization
491.79M
Intraday BUY SELL Signals
SCLX
Price
$17.87
Change
-$1.05 (-5.55%)
Updated
Nov 13 closing price
Capitalization
135.29M
Intraday BUY SELL Signals
Interact to see
Advertisement

JCRRF vs SCLX

Header iconJCRRF vs SCLX Comparison
Open Charts JCRRF vs SCLXBanner chart's image
JCR PHARMACEUTICALS
PriceLoading...
Change-$0.00 (-0.00%)
Volume$200
Capitalization491.79M
Scilex Holding
Price$17.87
Change-$1.05 (-5.55%)
Volume$66.97K
Capitalization135.29M
JCRRF vs SCLX Comparison Chart in %
JCRRF
Daily Signal:
Gain/Loss:
SCLX
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
JCRRF vs. SCLX commentary
Nov 14, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is JCRRF is a Hold and SCLX is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Nov 14, 2025
Stock price -- (JCRRF: $4.50 vs. SCLX: $18.92)
Brand notoriety: JCRRF and SCLX are both not notable
Both companies represent the Pharmaceuticals: Major industry
Current volume relative to the 65-day Moving Average: JCRRF: 25% vs. SCLX: 40%
Market capitalization -- JCRRF: $491.79M vs. SCLX: $135.29M
JCRRF [@Pharmaceuticals: Major] is valued at $491.79M. SCLX’s [@Pharmaceuticals: Major] market capitalization is $135.29M. The market cap for tickers in the [@Pharmaceuticals: Major] industry ranges from $915.49B to $0. The average market capitalization across the [@Pharmaceuticals: Major] industry is $98.13B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

JCRRF’s FA Score shows that 1 FA rating(s) are green whileSCLX’s FA Score has 0 green FA rating(s).

  • JCRRF’s FA Score: 1 green, 4 red.
  • SCLX’s FA Score: 0 green, 5 red.
According to our system of comparison, JCRRF is a better buy in the long-term than SCLX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

JCRRF’s TA Score shows that 0 TA indicator(s) are bullish while SCLX’s TA Score has 4 bullish TA indicator(s).

  • JCRRF’s TA Score: 0 bullish, 3 bearish.
  • SCLX’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, SCLX is a better buy in the short-term than JCRRF.

Price Growth

JCRRF (@Pharmaceuticals: Major) experienced а 0.00% price change this week, while SCLX (@Pharmaceuticals: Major) price change was +2.44% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Major industry was +3.48%. For the same industry, the average monthly price growth was +1.46%, and the average quarterly price growth was +19.41%.

Industries' Descriptions

@Pharmaceuticals: Major (+3.48% weekly)

The Major Pharmaceuticals industry includes companies that are involved in various processes of creating drugs to treat/prevent diseases. These companies engage in research, testing and manufacturing, as well as the distribution of pharmaceuticals into markets. Johnson & Johnson, Merck & Co., Inc., Pfizer Inc. and Novartis are among the largest companies in this category.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
JCRRF($492M) has a higher market cap than SCLX($135M). SCLX YTD gains are higher at: 26.776 vs. JCRRF (-1.532). JCRRF has higher annual earnings (EBITDA): 3.21B vs. SCLX (-70.91M). JCRRF has more cash in the bank: 18.3B vs. SCLX (4.1M). SCLX has less debt than JCRRF: SCLX (41.8M) vs JCRRF (28.4B). JCRRF has higher revenues than SCLX: JCRRF (35.3B) vs SCLX (44.2M).
JCRRFSCLXJCRRF / SCLX
Capitalization492M135M364%
EBITDA3.21B-70.91M-4,521%
Gain YTD-1.53226.776-6%
P/E Ratio20.45N/A-
Revenue35.3B44.2M79,864%
Total Cash18.3B4.1M446,450%
Total Debt28.4B41.8M67,943%
TECHNICAL ANALYSIS
Technical Analysis
JCRRFSCLX
RSI
ODDS (%)
Bearish Trend 2 days ago
25%
Bullish Trend 2 days ago
90%
Stochastic
ODDS (%)
N/A
Bearish Trend 2 days ago
47%
Momentum
ODDS (%)
N/A
Bullish Trend 2 days ago
48%
MACD
ODDS (%)
N/A
Bullish Trend 2 days ago
51%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
9%
Bullish Trend 2 days ago
50%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
6%
Bullish Trend 2 days ago
40%
Advances
ODDS (%)
N/A
Bullish Trend 2 days ago
73%
Declines
ODDS (%)
N/A
Bearish Trend 8 days ago
87%
BollingerBands
ODDS (%)
N/A
Bearish Trend 2 days ago
41%
Aroon
ODDS (%)
Bearish Trend 2 days ago
21%
Bearish Trend 2 days ago
85%
View a ticker or compare two or three
Interact to see
Advertisement
JCRRF
Daily Signal:
Gain/Loss:
SCLX
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
IGNYX20.380.23
+1.14%
Macquarie Natural Resources Y
LMOFX48.440.26
+0.54%
Patient Opportunity FI
FEREX12.780.04
+0.31%
First Eagle Global Real Assets I
VINAX152.960.14
+0.09%
Vanguard Industrials Index Admiral
IHSSX27.75-0.12
-0.43%
Hartford Small Company R4

JCRRF and

Correlation & Price change

A.I.dvisor tells us that JCRRF and SNYNF have been poorly correlated (+8% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that JCRRF and SNYNF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To JCRRF
1D Price
Change %
JCRRF100%
N/A
SNYNF - JCRRF
8%
Poorly correlated
N/A
SCLX - JCRRF
4%
Poorly correlated
+0.32%
MIRA - JCRRF
2%
Poorly correlated
-1.38%
CSWYF - JCRRF
0%
Poorly correlated
N/A
VRBCF - JCRRF
-0%
Poorly correlated
N/A
More

SCLX and

Correlation & Price change

A.I.dvisor tells us that SCLX and BIIB have been poorly correlated (+20% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that SCLX and BIIB's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SCLX
1D Price
Change %
SCLX100%
+0.32%
BIIB - SCLX
20%
Poorly correlated
+1.20%
AMRN - SCLX
20%
Poorly correlated
+0.75%
SNY - SCLX
9%
Poorly correlated
+0.44%
ABBV - SCLX
8%
Poorly correlated
+3.58%
RHHVF - SCLX
8%
Poorly correlated
+1.08%
More